Gesynta Pharma
Roger Franklin holds a Ph.D. in oncology from the University of Cambridge. Roger has more than 15 years of experience in the life science industry, including positions as a senior analyst in pharmaceuticals and biotech at a London-based investment bank and as an investment manager at a large London-based life science venture capital fund. Roger currently serves as a Partner at Hadean Ventures, a Stockholm/Oslo-based European life science venture fund.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Gesynta Pharma
Developing unique drug candidates aiming to reduce harmful inflammation and increase blood flow in the body’s microvasculature.